Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF – Get Free Report)’s share price was down 27.3% during trading on Monday . The stock traded as low as C$65.86 and last traded at C$65.86. Approximately 200 shares changed hands during trading, a decline of 85% from the average daily volume of 1,300 shares. The stock had previously closed at C$90.61.
Laboratorios Farmaceuticos Rovi Stock Performance
The company has a 50 day moving average of C$90.61 and a 200 day moving average of C$89.42.
About Laboratorios Farmaceuticos Rovi
Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.
Further Reading
- Five stocks we like better than Laboratorios Farmaceuticos Rovi
- Golden Cross Stocks: Pattern, Examples and Charts
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- 3 Stocks to Consider Buying in October
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Laboratorios Farmaceuticos Rovi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratorios Farmaceuticos Rovi and related companies with MarketBeat.com's FREE daily email newsletter.